ArticleProceedings of the National Academy of Sciences of the United States of America2024

PurA is the main target of aurodox, a type III secretion system inhibitor.

Yoshihiro Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.